Traumatic Brain Injury Outcomes After Recreational Cannabis Use

Overview

Journal Neuropsychiatr Dis Treat

Publisher Dove Medical Press

Specialty Psychiatry

Date 2024 Apr 8

PMID 38586307

Authors

Jerzy P Szaflarski

Magdalena Szaflarski

Affiliations

Soon will be listed here.

Abstract

Purpose: Basic science data indicate potential neuroprotective effects of cannabinoids in traumatic brain injury (TBI). We aimed to evaluate the effects of pre-TBI recreational cannabis use on TBI outcomes.

Patients And Methods: We used i2b2 (a scalable informatics framework; www.i2b2.org) to identify all patients presenting with acute TBI between 1/1/2014 and 12/31/2016, then conducted a double-abstraction medical chart review to compile basic demographic, urine drug screen (UDS), Glasgow Coma Scale (GCS), and available outcomes data (mortality, modified Rankin Scale (mRS), duration of stay, disposition (home, skilled nursing facility, inpatient rehabilitation, other)) at discharge and at specific time points thereafter. We conducted multivariable nested ordinal and logistic regression analyses to estimate associations between cannabis use, other UDS results, demographic factors, and selected outcomes.

Results: i2b2 identified 6396 patients who acutely presented to our emergency room with TBI. Of those, 3729 received UDS, with 22.2% of them testing positive for cannabis. Mortality was similar in patients who tested positive vs negative for cannabis (3.9% vs 4.8%; p = 0.3) despite more severe GCS on admission in the cannabis positive group (p = 0.045). Several discharge outcome measures favored the cannabis positive group who had a higher rate of discharge home vs other care settings (p < 0.001), lower discharge mRS (p < 0.001), and shorter duration of hospital stay (p < 0.001) than the UDS negative group. Multivariable analyses confirmed mostly independent associations between positive cannabis screen and these post-TBI short- and long-term outcomes.

Conclusion: This study adds evidence about the potentially neuroprotective effects of recreational cannabis for short- and long-term post-TBI outcomes. These results need to be confirmed via prospective data collections.

References

Banks J, Marotta C . Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007; 38(3):1091-6. DOI: 10.1161/01.STR.0000258355.23810.c6. View

Nguyen B, Kim D, Bricker S, Bongard F, Neville A, Putnam B . Effect of marijuana use on outcomes in traumatic brain injury. Am Surg. 2014; 80(10):979-83. View

Czigner A, Mihaly A, Farkas O, Buki A, Krisztin-Peva B, Dobo E . Kinetics of the cellular immune response following closed head injury. Acta Neurochir (Wien). 2007; 149(3):281-9. DOI: 10.1007/s00701-006-1095-8. View

Foreman B, Caesar R, Parks J, Madden C, Gentilello L, Shafi S . Usefulness of the abbreviated injury score and the injury severity score in comparison to the Glasgow Coma Scale in predicting outcome after traumatic brain injury. J Trauma. 2007; 62(4):946-50. DOI: 10.1097/01.ta.0000229796.14717.3a. View

Hawley L, Ketchum J, Morey C, Collins K, Charlifue S . Cannabis Use in Individuals With Spinal Cord Injury or Moderate to Severe Traumatic Brain Injury in Colorado. Arch Phys Med Rehabil. 2018; 99(8):1584-1590. DOI: 10.1016/j.apmr.2018.02.003. View

Hampson A, Grimaldi M, Axelrod J, Wink D . Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci U S A. 1998; 95(14):8268-73. PMC: 20965. DOI: 10.1073/pnas.95.14.8268. View

Menzel L, Kleber L, Friedrich C, Hummel R, Dangel L, Winter J . Progranulin protects against exaggerated axonal injury and astrogliosis following traumatic brain injury. Glia. 2016; 65(2):278-292. DOI: 10.1002/glia.23091. View

Hofmann M, Frazier C . Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention. Exp Neurol. 2011; 244:43-50. PMC: 3332149. DOI: 10.1016/j.expneurol.2011.11.047. View

Maroon J, Bost J . Review of the neurological benefits of phytocannabinoids. Surg Neurol Int. 2018; 9:91. PMC: 5938896. DOI: 10.4103/sni.sni_45_18. View

10.

Knoller N, Levi L, Shoshan I, Reichenthal E, Razon N, Rappaport Z . Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial. Crit Care Med. 2002; 30(3):548-54. DOI: 10.1097/00003246-200203000-00009. View

11.

Chiu C, Liao Y, Yang L, Wang J, Tweedie D, Karnati H . Neuroinflammation in animal models of traumatic brain injury. J Neurosci Methods. 2016; 272:38-49. PMC: 5201203. DOI: 10.1016/j.jneumeth.2016.06.018. View

12.

Librizzi L, Noe F, Vezzani A, de Curtis M, Ravizza T . Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol. 2012; 72(1):82-90. DOI: 10.1002/ana.23567. View

13.

Pacher P, Kunos G . Modulating the endocannabinoid system in human health and disease--successes and failures. FEBS J. 2013; 280(9):1918-43. PMC: 3684164. DOI: 10.1111/febs.12260. View

14.

Graham N, Sharp D . Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia. J Neurol Neurosurg Psychiatry. 2019; 90(11):1221-1233. PMC: 6860906. DOI: 10.1136/jnnp-2017-317557. View

15.

Nikolian V, Dekker S, Bambakidis T, Higgins G, Dennahy I, Georgoff P . Improvement of Blood-Brain Barrier Integrity in Traumatic Brain Injury and Hemorrhagic Shock Following Treatment With Valproic Acid and Fresh Frozen Plasma. Crit Care Med. 2017; 46(1):e59-e66. DOI: 10.1097/CCM.0000000000002800. View

16.

Van Praag D, Cnossen M, Polinder S, Wilson L, Maas A . Post-Traumatic Stress Disorder after Civilian Traumatic Brain Injury: A Systematic Review and Meta-Analysis of Prevalence Rates. J Neurotrauma. 2019; 36(23):3220-3232. PMC: 6857464. DOI: 10.1089/neu.2018.5759. View

17.

Temkin N, Dikmen S, Wilensky A, Keihm J, Chabal S, Winn H . A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med. 1990; 323(8):497-502. DOI: 10.1056/NEJM199008233230801. View

18.

Preuss U, Huestis M, Schneider M, Hermann D, Lutz B, Hasan A . Cannabis Use and Car Crashes: A Review. Front Psychiatry. 2021; 12:643315. PMC: 8195290. DOI: 10.3389/fpsyt.2021.643315. View

19.

Ravizza T, Balosso S, Vezzani A . Inflammation and prevention of epileptogenesis. Neurosci Lett. 2011; 497(3):223-30. DOI: 10.1016/j.neulet.2011.02.040. View

20.

Ahmed Z . Current Clinical Trials in Traumatic Brain Injury. Brain Sci. 2022; 12(5). PMC: 9138587. DOI: 10.3390/brainsci12050527. View